{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T09:29:29Z","timestamp":1786526969819,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ratchadapisek Research Fund","award":["GA69\/064"],"award-info":[{"award-number":["GA69\/064"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Res."],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s44313-026-00161-2","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:36:52Z","timestamp":1786523812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clonal hematopoietic mutations as a predictor of adverse outcomes in cytopenic patients with chronic kidney disease"],"prefix":"10.1007","volume":"61","author":[{"given":"Suwannaporn","family":"Yaophrukchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantana","family":"Polprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirorat","family":"Kobbuaklee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponlapat","family":"Rojnuckarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunisa","family":"Kongkiatkamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"26","key":"161_CR1","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488\u201398.","journal-title":"N Engl J Med"},{"issue":"7","key":"161_CR2","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"issue":"11","key":"161_CR3","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200\u201328.","journal-title":"Blood"},{"key":"161_CR4","doi-asserted-by":"crossref","unstructured":"Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366(6465).","DOI":"10.1126\/science.aan4673"},{"issue":"26","key":"161_CR5","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G, K\u00e4hler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477\u201387.","journal-title":"N Engl J Med"},{"issue":"6","key":"161_CR6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","volume":"130","author":"F Zink","year":"2017","unstructured":"Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood. 2017;130(6):742\u201352.","journal-title":"Blood"},{"issue":"3","key":"161_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41581-023-00778-x","volume":"20","author":"C Vlasschaert","year":"2024","unstructured":"Vlasschaert C, Lanktree MB, Rauh MJ, Kelly TN, Natarajan P. Clonal haematopoiesis, ageing and kidney disease. Nat Rev Nephrol. 2024;20(3):161\u201374.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"161_CR8","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1681\/ASN.0000000680","volume":"36","author":"C Vlasschaert","year":"2025","unstructured":"Vlasschaert C, Pan Y, Chen J, Akwo E, Rao V, Hixson JE, et al. Clonal hematopoiesis of indeterminate potential and progression of CKD. J Am Soc Nephrol. 2025;36(9):1764\u201374.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"161_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal S, Natarajan P, Silver AJ, Gibson CJ, Bick AG, Shvartz E, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111\u201321.","journal-title":"N Engl J Med"},{"issue":"14","key":"161_CR10","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1182\/bloodadvances.2024013228","volume":"8","author":"J Singh","year":"2024","unstructured":"Singh J, Li N, Ashrafi E, Thao LTP, Curtis DJ, Wood EM, et al. Clonal hematopoiesis of indeterminate potential as a prognostic factor: a systematic review and meta-analysis. Blood Adv. 2024;8(14):3771\u201384.","journal-title":"Blood Adv"},{"issue":"1","key":"161_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jacc.2021.04.085","volume":"78","author":"B Yu","year":"2021","unstructured":"Yu B, Roberts MB, Raffield LM, Zekavat SM, Nguyen NQH, Biggs ML, et al. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure. J Am Coll Cardiol. 2021;78(1):42\u201352.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"161_CR12","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.jacc.2021.02.028","volume":"77","author":"DA Pascual-Figal","year":"2021","unstructured":"Pascual-Figal DA, Bayes-Genis A, D\u00edez-D\u00edez M, Hern\u00e1ndez-Vicente \u00c1, V\u00e1zquez-Andr\u00e9s D, de la Barrera J, et al. Clonal hematopoiesis and risk of progression of heart failure with reduced left ventricular ejection fraction. J Am Coll Cardiol. 2021;77(14):1747\u201359.","journal-title":"J Am Coll Cardiol"},{"key":"161_CR13","doi-asserted-by":"publisher","first-page":"1181879","DOI":"10.3389\/fpubh.2023.1181879","volume":"11","author":"MJ Kim","year":"2023","unstructured":"Kim MJ, Song H, Koh Y, Lee H, Park HE, Choi SH, et al. Clonal hematopoiesis as a novel risk factor for type 2 diabetes mellitus in patients with hypercholesterolemia. Front Public Health. 2023;11:1181879.","journal-title":"Front Public Health"},{"issue":"3","key":"161_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1053\/j.ajkd.2022.08.014","volume":"81","author":"B Kestenbaum","year":"2023","unstructured":"Kestenbaum B, Bick AG, Vlasschaert C, Rauh MJ, Lanktree MB, Franceschini N, et al. Clonal hematopoiesis of indeterminate potential and kidney function decline in the general population. Am J Kidney Dis. 2023;81(3):329\u201335.","journal-title":"Am J Kidney Dis"},{"key":"161_CR15","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.0000000895","author":"K Sumida","year":"2025","unstructured":"Sumida K, Obeng EA, Kovesdy CP. Clonal hematopoiesis in kidney disease. Clin J Am Soc Nephrol. 2025. https:\/\/doi.org\/10.2215\/cjn.0000000895.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"161_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1681\/ASN.2021060774","volume":"33","author":"C Vlasschaert","year":"2022","unstructured":"Vlasschaert C, McNaughton AJM, Chong M, Cook EK, Hopman W, Kestenbaum B, et al. Association of clonal hematopoiesis of indeterminate potential with worse kidney function and anemia in two cohorts of patients with advanced chronic kidney disease. J Am Soc Nephrol. 2022;33(5):985\u201395.","journal-title":"J Am Soc Nephrol"},{"key":"161_CR17","unstructured":"Vlasschaert C, Pan Y, Chen J, Akwo E, Rao V, Hixson JE, et al. Clonal hematopoiesis of indeterminate potential contributes to accelerated chronic kidney disease progression. medRxiv. 2024."},{"issue":"3","key":"161_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/blood.2021013531","volume":"139","author":"PG Miller","year":"2022","unstructured":"Miller PG, Qiao D, Rojas-Quintero J, Honigberg MC, Sperling AS, Gibson CJ, et al. Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood. 2022;139(3):357\u201368.","journal-title":"Blood"},{"issue":"14","key":"161_CR19","first-page":"1606","volume":"136","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S. Clonal hematopoiesis and nonhematologic disorders. Blood. 2020;136(14):1606\u201314.","journal-title":"Blood"},{"issue":"20","key":"161_CR20","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/j.jacc.2023.03.401","volume":"81","author":"ED Gumuser","year":"2023","unstructured":"Gumuser ED, Schuermans A, Cho SMJ, Sporn ZA, Uddin MM, Paruchuri K, et al. Clonal hematopoiesis of indeterminate potential predicts adverse outcomes in patients with atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2023;81(20):1996\u20132009.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"161_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/svn-2022-001756","volume":"8","author":"X Qiu","year":"2023","unstructured":"Qiu X, Dai Y, Cheng S, Gu HQ, Jiang Y, Meng X, et al. Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort study. Stroke Vasc Neurol. 2023;8(2):103\u201310.","journal-title":"Stroke Vasc Neurol"},{"issue":"3","key":"161_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41591-024-02854-6","volume":"30","author":"C Vlasschaert","year":"2024","unstructured":"Vlasschaert C, Robinson-Cohen C, Chen J, Akwo E, Parker AC, Silver SA, et al. Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury. Nat Med. 2024;30(3):810\u20137.","journal-title":"Nat Med"},{"key":"161_CR23","doi-asserted-by":"crossref","unstructured":"Kunanon S, Chattranukulchai P, Chotruangnapa C, Kositanurit W, Methavigul K, Boonyasirinant T, et al. 2019 Thai guidelines on the treatment of hypertension: executive summary. Journal of the Medical Association of Thailand. 2021;104(10).","DOI":"10.35755\/jmedassocthai.2021.10.12199"},{"issue":"20","key":"161_CR24","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"issue":"11","key":"161_CR25","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2012","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2012;158(11):825\u201330.","journal-title":"Ann Intern Med"},{"issue":"3","key":"161_CR26","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/STROKEAHA.121.037388","volume":"53","author":"R Bhattacharya","year":"2022","unstructured":"Bhattacharya R, Zekavat SM, Haessler J, Fornage M, Raffield L, Uddin MM, et al. Clonal hematopoiesis is associated with higher risk of stroke. Stroke. 2022;53(3):788\u201397.","journal-title":"Stroke"},{"issue":"2","key":"161_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41375-021-01382-3","volume":"36","author":"AAZ Dawoud","year":"2022","unstructured":"Dawoud AAZ, Gilbert RD, Tapper WJ, Cross NCP. Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease. Leukemia. 2022;36(2):507\u201315.","journal-title":"Leukemia"},{"issue":"1","key":"161_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000489042","volume":"86","author":"P Valent","year":"2019","unstructured":"Valent P. ICUS, IDUS, CHIP and CCUS: diagnostic criteria, separation from MDS and clinical implications. Pathobiology. 2019;86(1):30\u20138.","journal-title":"Pathobiology"},{"issue":"6","key":"161_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jamacardio.2024.0459","volume":"9","author":"S Saadatagah","year":"2024","unstructured":"Saadatagah S, Naderian M, Uddin M, Dikilitas O, Niroula A, Schuermans A, et al. Atrial fibrillation and clonal hematopoiesis in TET2 and ASXL1. JAMA Cardiol. 2024;9(6):497\u2013506.","journal-title":"JAMA Cardiol"},{"issue":"7831","key":"161_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","volume":"586","author":"AG Bick","year":"2020","unstructured":"Bick AG, Weinstock JS, Nandakumar SK, Fulco CP, Bao EL, Zekavat SM, et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020;586(7831):763\u20138.","journal-title":"Nature"}],"container-title":["Blood Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-026-00161-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44313-026-00161-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44313-026-00161-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:36:56Z","timestamp":1786523816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44313-026-00161-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1007\/s44313-026-00161-2","relation":{},"ISSN":["2287-979X","2288-0011"],"issn-type":[{"value":"2287-979X","type":"print"},{"value":"2288-0011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of the Faculty of Medicine at Chulalongkorn University (approval number 0633\/67). The requirement for informed consent was waived owing to the retrospective design.","order":1,"name":"Ethics","label":"Ethics approval and consent to paticipate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"42"}}